SCHEMBL6803364

SCHEMBL6803364

COc1ccc(-c2ccccc2C(=O)Nc2ccc3c(c2)CCN3)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.61
POLB P06746 1/20 0.61
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 3/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 1/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTT P42858 1/20 0.47
APOB P04114 3/20 0.46
MTTP P55157 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
KDR P35968 1/20 0.46
METAP2 P50579 1/20 0.45
ATM Q13315 1/20 0.44
PNLIP P16233 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665172 0.89 GAA (0.54) GAAPOLBKDM4EALDH1A1MAPT
SCHEMBL6804465 0.88 L3MBTL1 (0.52) GAAPOLBKDM4EALDH1A1MEN1
Hydrochloric Acid SCHEMBL6803617 0.87 L3MBTL1 (0.51) GAAPOLBKDM4EALDH1A1MEN1
SCHEMBL6662843 0.86 SLC2A1 (0.49) ALDH1A1MEN1KMT2ALMNATSHR
SCHEMBL6802225 0.86 MAOB (0.44) GAAPOLBKDM4EALDH1A1MAPT
SCHEMBL6803227 0.84 APOB (0.48) MEN1KMT2ALMNAAPOBMTTP
SCHEMBL6645543 0.83 MTTP (0.61) GAAKDM4EALDH1A1MAPTLMNA
SCHEMBL6808697 0.82 MAPT (0.49) POLBALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL6803931 0.82 MTTP (0.60) GAAKDM4EALDH1A1MAPTLMNA
SCHEMBL6662272 0.79 L3MBTL1 (0.51) GAAKDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 GAA 2694/4885POLB 1962/4885KDM4E 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.